Humana (NYSE:HUM – Free Report) had its price objective trimmed by Barclays from $356.00 to $310.00 in a report released on Tuesday, Benzinga reports. The firm currently has an equal weight rating on the insurance provider’s stock. Other equities analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from […]